Cancer
Malignant Colon Neoplasm
CI-CAN-00007995Explore in graph →
Top-level225 active trials5 approved drugs17 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00007995Explore in graph →
Clinical trials
1,197 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (139)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06050447 | Factors Affecting the Results of Treatment of Patients With Colorectal Cancer | unknown | — | 1,200 | Immanuel Kant Baltic Federal UniversityOTHER | 1 | Sep 22, 2023 | clinicaltrials |
| NCT01376505 | Vaccine Therapy in Treating Patients With Metastatic Solid Tumors | completed | Phase 1 | 65 | Robert WesolowskiOTHER | 1 | Sep 15, 2023 | clinicaltrials |
| NCT00591279 |
| Cancer Control Following Polypectomy |
| completed |
| — |
| 110 |
| Memorial Sloan Kettering Cancer CenterOTHER |
| 1 |
| Sep 13, 2023 |
| clinicaltrials |
| NCT01606098 | The Role of Surgery of the Primary Tumour in Patients With Synchronous Unresectable Metastases of Colorectal Cancer(CAIRO4) | completed | Phase 3 | 206 | Dutch Colorectal Cancer GroupOTHER | 2 | Sep 13, 2023 | clinicaltrials |
| NCT03827967 | Trial of PalloV-CC in Colon Cancer | completed | Phase 1 | 24 | George E. PeoplesINDUSTRY | 1 | Sep 13, 2023 | clinicaltrials |
| NCT04880772 | Clinical Trial Comparing Standard Care Versus Prehabilitation in Patients Undergoing Cancer Surgery(SPECS) | completed | N/A | 42 | East Lancashire Hospitals NHS TrustOTHER | 1 | Sep 7, 2023 | clinicaltrials |
| NCT06017141 | Inhalational or Intravenous Anesthesia During Surgery for Patients With Colon Cancer, VIVA Study | unknown | Phase 2 | 80 | University of Kansas Medical CenterOTHER | 1 | Aug 30, 2023 | clinicaltrials |
| NCT06009484 | VTE Incidence After Curative Colon Cancer Surgery in an ERAS Program | completed | — | 2,141 | Nordsjaellands HospitalOTHER | 0 | Aug 24, 2023 | clinicaltrials |
| NCT02726360 | Physician Use of Non-English Language Skills in Cancer Care | completed | — | 71 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 23, 2023 | clinicaltrials |
| NCT04716010 | Developing and Evaluating Product Messaging | completed | N/A | 4,160 | University of North Carolina, Chapel HillOTHER | 1 | Aug 18, 2023 | clinicaltrials |
| NCT04798612 | Effect of Low-dose Interferon-alfa2a on Peri-operative Immune Suppression(IPOS) | unknown | Phase 2 | 68 | Zealand University HospitalOTHER | 1 | Aug 18, 2023 | clinicaltrials |
| NCT00994864 | Preoperative Chemosensitivity Testing to Predict Treatment Benefit in Adjuvant Stage III Colon Cancer(PePiTA) | completed | N/A | 235 | Jules Bordet InstituteOTHER | 1 | Aug 7, 2023 | clinicaltrials |
| NCT02232152 | CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery | completed | Phase 1 | 19 | Wake Forest University Health SciencesOTHER | 1 | Aug 7, 2023 | clinicaltrials |
| NCT03602079 | Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene | completed | Phase 1 / Phase 2 | 49 | Klus Pharma Inc.INDUSTRY | 1 | Aug 3, 2023 | clinicaltrials |
| NCT04048421 | Feasibility and Safety of Hybrid Transvaginal Natural Orifice Transluminal Endoscopic Surgery for Colon Cancer | unknown | N/A | 55 | Renmin Hospital of Wuhan UniversityOTHER | 1 | Aug 3, 2023 | clinicaltrials |
| NCT05973266 | The Effect of Mobile Application-Based Bowel Preparation Training on the Patient's Education Whom Colonoscopy is Planned | unknown | N/A | 160 | Kubra SengorOTHER | 1 | Aug 3, 2023 | clinicaltrials |
| NCT04971304 | Comparative Effectiveness Analysis of Granulocyte Colony Stimulating Factor Originator Products Versus Biosimilars | completed | — | 16,506 | Catherine M. LockhartOTHER | 0 | Jul 27, 2023 | clinicaltrials |
| NCT05734300 | The "SPARCOL" Study | recruiting | N/A | 48 | Zealand University HospitalOTHER | 1 | Jul 25, 2023 | clinicaltrials |
| NCT05916443 | Dissecting the Biology of Early-onset Colorectal Cancer | unknown | — | 30 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 0 | Jul 24, 2023 | clinicaltrials |
| NCT05726188 | Predictors of Disease Recurrence After Curative Surgery for Stage I Colon Cancer(CORE1) | unknown | — | 2,000 | Azienda Ospedaliera Universitaria Integrata VeronaOTHER | 2 | Jul 21, 2023 | clinicaltrials |
| NCT03717519 | Elevated Platelet Count as Prognostic Factor in Colorectal Cancer With Synchronous Liver Metastases(PLTCRC) | completed | — | 196 | Azienda Ospedaliera Universitaria Integrata VeronaOTHER | 1 | Jul 20, 2023 | clinicaltrials |
| NCT05943951 | Italian Study on the Right Hemicolectomy: How the Lymphadenectomy is Performed(CoDIG-2) | completed | — | 788 | Gabriele AnaniaOTHER | 1 | Jul 13, 2023 | clinicaltrials |
| NCT05916001 | Preoperative Immunonutrition in Patients Undergoing Elective Colorectal Surgery for Neoplasm | unknown | N/A | 216 | University of Roma La SapienzaOTHER | 0 | Jun 23, 2023 | clinicaltrials |
| NCT01347645 | Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer | terminated | Phase 1 / Phase 2 | 82 | Eisai Inc.INDUSTRY | 6 | Jun 22, 2023 | clinicaltrials |
| NCT03428126 | Study of Durvalumab (MEDI4736) (Anti-PD-L1) and Trametinib (MEKi) in MSS Metastatic Colon Cancer | completed | Phase 2 | 29 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 15, 2023 | clinicaltrials |
| NCT05715905 | Analyzing Clinical Trial Experiences of Colon Cancer Patients | unknown | — | 500 | Power Life Sciences Inc.INDUSTRY | 0 | Jun 12, 2023 | clinicaltrials |
| NCT04902144 | Clinical Outcomes for Offering Genetic Testing in a Tiered Approach | completed | N/A | 6 | Fred Hutchinson Cancer CenterOTHER | 1 | Jun 9, 2023 | clinicaltrials |
| NCT05438771 | The Effects of Ankaferd Blood Stopper(ABS) | unknown | N/A | 66 | Uludag UniversityOTHER | 1 | Jun 1, 2023 | clinicaltrials |
| NCT05030090 | Integrative Nutrition Care Plan for the Patient With Liver and Colorectal Cancer | completed | N/A | 66 | Taipei Medical UniversityOTHER | 1 | May 31, 2023 | clinicaltrials |
| NCT05596188 | Anxiety Before Non-cardiac Surgery in Adults | unknown | — | 424 | RenJi HospitalOTHER | 1 | May 31, 2023 | clinicaltrials |
| NCT05875402 | XKDCT080 in GCC-positive Recurrent or Refractory Solid Tumors With Single Center, Single Arm, and Dose Escalation | unknown | N/A | 9 | The Affiliated Hospital of Qingdao UniversityOTHER | 1 | May 25, 2023 | clinicaltrials |
| NCT05872334 | The Safety and Feasibility of MONOFIX on Fascial Closure of Mid-line Wound After Minimally Invasive Colorectal Cancer Surgery | completed | N/A | 120 | Samsung Medical CenterOTHER | 1 | May 24, 2023 | clinicaltrials |
| NCT01488045 | Compare Propofol to Fentanyl and Midazolam for Colonoscopy | completed | N/A | 289 | Trinity Health MichiganOTHER | 1 | May 23, 2023 | clinicaltrials |
| NCT04959604 | Lymph Node Mapping Via Flourescent Dye in Colon Cancer | recruiting | N/A | 30 | Universitätsklinikum Hamburg-EppendorfOTHER | 1 | May 23, 2023 | clinicaltrials |
| NCT02849717 | Pre-Habilitation Exercise Intervention | completed | N/A | 82 | University of RochesterOTHER | 1 | May 16, 2023 | clinicaltrials |
| NCT03028831 | Fiber to Reduce Colon Cancer in Alaska Native People | completed | N/A | 48 | University of PittsburghOTHER | 1 | May 16, 2023 | clinicaltrials |
| NCT05859581 | The Value of MRI in Assessing the Status of Retroperitoneal Resection Margin in Colon Cancer | unknown | N/A | 29 | Peking University Cancer Hospital & InstituteOTHER | 1 | May 16, 2023 | clinicaltrials |
| NCT01420874 | Anti-CD3 x Anti-Erbitux® Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer) | completed | Phase 1 | 15 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | May 6, 2023 | clinicaltrials |
| NCT02974556 | Proactive Management of Endoperitoneal Spread in Colonic Cancer(PROMENADE) | unknown | Phase 3 | 140 | University of Roma La SapienzaOTHER | 1 | May 6, 2023 | clinicaltrials |
| NCT05833672 | Neoadjuvant Immunotherapy in Locally Advanced Colon Cancers | unknown | Phase 2 | 100 | fan liOTHER | 1 | Apr 27, 2023 | clinicaltrials |
| NCT05827471 | Clinical Study of QSOX1 as a Biomarker for Colon Cancer | not yet recruiting | — | 400 | Qianfoshan HospitalOTHER | 0 | Apr 25, 2023 | clinicaltrials |
| NCT04882423 | Vegetable Intake Effect on Heterocyclic Amine Metabolism | terminated | N/A | 25 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Apr 19, 2023 | clinicaltrials |
| NCT05653934 | Use of VIrtual REAlity to Reduce Postoperative Anxiety and Pain After Surgery for Colorectal Cancer(VIREA) | unknown | N/A | 124 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Apr 19, 2023 | clinicaltrials |
| NCT05147545 | Impact of Exercise and Hyperlipidic Meal on Free Circulating DNA in Patients With Metastatic Colonic Cancer and Healthy Subjects(ASRHACOLS) | unknown | N/A | 60 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Apr 18, 2023 | clinicaltrials |
| NCT05801211 | Colonic Resection or Stoma, or Self-expandable Metallic Stent for obstruCtive Left cOlon Cancer(CROSCO-1) | unknown | — | 434 | Azienda Sanitaria di FirenzeOTHER | 0 | Apr 13, 2023 | clinicaltrials |
| NCT05553080 | Significance of Immunohistochemical Expression of Fascin-1 in Colorectal Carcinoma | completed | — | 60 | Sohag UniversityOTHER | 1 | Apr 12, 2023 | clinicaltrials |
| NCT05795725 | Evaluation of the Diagnostic Potential of Artificial Intelligence-assisted Fecal Microbiome Testing for Colon Cancer | unknown | N/A | 1,000 | Istanbul Medipol University HospitalOTHER | 1 | Apr 3, 2023 | clinicaltrials |
| NCT05546892 | Short-term Outcomes of Full Bowel Preparation (MBP+OA) for Colon Cancer Resections Versus no Bowel Preparation(COLRABI) | unknown | N/A | 586 | N.N. Petrov National Medical Research Center of OncologyOTHER | 1 | Mar 29, 2023 | clinicaltrials |
| NCT03801915 | Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers | completed | Phase 2 | 10 | National Cancer Institute (NCI)NIH | 1 | Mar 21, 2023 | clinicaltrials |
| NCT05754060 | Cognitive Processing Slowness as a Marker of Cognitive Impairment in Non-central Nervous System Cancer Patients(RIVAGE) | unknown | — | 200 | Assistance Publique - Hôpitaux de ParisOTHER | 0 | Mar 8, 2023 | clinicaltrials |
Data updated 23 days agoSource updated Sep 22, 2023source: clinicaltrials